Until now, this insulin was only indicated in Spain for adults with diabetes.
Fiasp -Faster Aspart of Fast Action of Novo Nordisk -is now available in Spain for children from a year and adolescents with type 1 diabetes or type 2. Until now, this novel insulin for its mechanism of action was only indicated inSpain for adults with diabetes."In the pediatric population, the main difficulty we are for the good control of diabetes is to avoid hyperglycemia that occur after meals," says Dr. Marta Ferrer, of the Pediatric Endocrinology Unit of the Miguel Servet Hospital(Saragossa).
This new insulin, explains Dr. Ferrer, represents a new generation of prandial insulins or faster action.Its initial absorption and peak of action are more early than the current fast -acting insulin anologists, which reduces the peak of early hyperglycemia that occurs at the time or hour and a half after eating. ”
For these age groups, it is recommended that FIASP be administered before meals (from 0 to 2 minutes before the start of the intake).However, FIASP can also be administered up to 20 minutes after the beginning of the intake (administration after food) on those occasions in which the person with diabetes does not surely know what time it will eat.
complications in pediatric population
"It is estimated that in our country the incidence of type 1 diabetes in children under 15 is 15-20 new cases per 100,000 children/year," says the expert.Adolescents, continues, are the age group in which it is more difficult to achieve glycemic objectives (in general, glycosylated hemoglobin & lt; 7%)."An objective that reaches less than half of adolescents, between 30-40%."
The most common complications in the pediatric population because of poor diabetes control are minor, serious hypoglycemia and hyperglycemic decompensation with risk of ketoacidosis.“Although its frequency is slowly decreasing thanks to the new treatments, devices and diabetological education.The latter is a necessary pillar for advances to translate into an improvement in glycemic control.But it must be carried out from the diagnosis of the disease and, in the specific case of children, the involvement of the family is key, ”warns Dr. Marta Ferrer.